Free Trial
CVE:MPH

Medicure (MPH) Stock Price, News & Analysis

Medicure logo
C$1.11 -0.09 (-7.50%)
As of 07/16/2025 03:19 PM Eastern

About Medicure Stock (CVE:MPH)

Key Stats

Today's Range
C$1.11
C$1.20
50-Day Range
C$0.83
C$1.27
52-Week Range
C$0.63
C$1.27
Volume
24,100 shs
Average Volume
4,488 shs
Market Capitalization
C$11.58 million
P/E Ratio
N/A
Dividend Yield
2.24%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

MPH Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Medicure Inc. (NGQ1.F)
Medicure Inc. (MPH.V)
MPH:CA Medicure Inc.
See More Headlines

MPH Stock Analysis - Frequently Asked Questions

Medicure's stock was trading at C$0.88 at the beginning of 2025. Since then, MPH stock has increased by 26.1% and is now trading at C$1.11.

Medicure Inc. (CVE:MPH) announced its quarterly earnings data on Wednesday, May, 24th. The company reported ($0.33) earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by $0.37. The company had revenue of $8.71 million for the quarter, compared to the consensus estimate of $14.50 million. Medicure had a negative net margin of 9.65% and a negative trailing twelve-month return on equity of 10.18%.

Shares of MPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicure investors own include Dollarama (DOL), Alimentation Couche-Tard (ATD.B), Canoe EIT Income Fund (ENDTF), Allena Pharmaceuticals (ALNA), Hudbay Minerals (HBM), ProMetic Life Sciences (PLI) and Athersys (ATHX).

Company Calendar

Last Earnings
5/24/2017
Today
7/17/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:MPH
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
17.00
P/E Growth
N/A
Net Income
-C$2.03 million
Net Margins
-9.65%
Pretax Margin
N/A
Return on Equity
-10.18%
Return on Assets
-5.63%

Debt

Debt-to-Equity Ratio
4.65
Current Ratio
2.03
Quick Ratio
1.29

Sales & Book Value

Annual Sales
C$21.08 million
Price / Sales
0.55
Cash Flow
C$0.45 per share
Price / Cash Flow
2.49
Book Value
C$1.91 per share
Price / Book
0.58

Miscellaneous

Outstanding Shares
10,436,300
Free Float
N/A
Market Cap
C$11.58 million
Optionable
Not Optionable
Beta
0.90
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (CVE:MPH) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners